T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in T2 Biosystems, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +5 vs. Q3 2024
- Shares held
- 871.8K
- −1.28M (−59.5%) vs. Q3 2024
- Total value
- $365.9K
- −$3.87M (−91.4%) vs. Q3 2024
- New holders
- 9
- 5 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTOO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 2 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 26 | $365.9K |
| Q3 2024 | 21 | $4.24M |
| Q2 2024 | 21 | $12.6M |
| Q1 2024 | 19 | $519.8K |
| Q4 2023 | 21 | $1.37M |
| Q3 2023 | 44 | $4.06M |
| Q2 2023 | 32 | $451.5K |
| Q1 2023 | 34 | $1.55M |
| Q4 2022 | 27 | $667.5K |
| Q3 2022 | 62 | $2.79M |
| Q2 2022 | 68 | $3.07M |
| Q1 2022 | 76 | $7.97M |
| Q4 2021 | 79 | $9.92M |
| Q3 2021 | 79 | $21.1M |
| Q2 2021 | 84 | $33.0M |
| Q1 2021 | 84 | $42.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding T2 Biosystems, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 154,814 | $65.0K | 0.00% | −235,554−60.3% | Reduced |
| Geode Capital Management, LLC | 142,196 | $59.8K | 0.00% | +51,316+56.5% | Added |
| UBS Group AG | 139,240 | $58.5K | 0.00% | +139,239+13,923,900.0% | Added |
| Squarepoint Ops LLC | 92,983 | $39.1K | 0.00% | +92,983 | New |
| BlackRock, Inc. | 76,827 | $32.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 63,743 | $26.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 57,554 | $24.2K | 0.00% | +12,073+26.5% | Added |
| Virtu Financial LLC | 31,162 | $13.0K | 0.00% | +31,162 | New |
| Northern Trust Corp | 27,142 | $11.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 22,814 | $9.58K | 0.00% | +22,814 | New |
| Kingswood Wealth Advisors, LLC | 20,000 | $8.40K | 0.00% | +20,000 | New |
| Goldman Sachs Group Inc | 14,750 | $6.20K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 11,936 | $5.01K | 0.00% | +11,936 | New |
| Nordwand Advisors, LLC | 10,000 | $4.20K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 5,304 | $2.23K | 0.00% | +2,905+121.1% | Added |
| Group One Trading, L.P. | 289 | $121 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 237 | $100 | 0.00% | +237 | New |
| SBI Securities Co., Ltd. | 99 | $42 | 0.00% | +99 | New |
| Bank of America Corp | 82 | $34 | 0.00% | +26+46.4% | Added |
| Advisor Group Holdings, Inc. | 38 | $15 | 0.00% | −167−81.5% | Reduced |
| JPMorgan Chase & Co | 33 | $14 | 0.00% | +33 | New |
| Morgan Stanley | 14 | $6 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 271 | $0 | 0.00% | −3,730−93.2% | Reduced |
| CWM, LLC | 310 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $0 | 0.00% | −100−99.0% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,396,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −39,140−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |